Pipeline / Targeted Indication / Pulmonary Hypertension (PH) WHO Group 1 (PAH)

Tyvaso DPI™ (inhaled treprostinil)
RemoLife (treprostinil)
OreniPro™ (once-daily, oral treprostinil prodrug)
RemoPro™ (treprostinil prodrug)
ADVANCE Studies Ralinepag (IP receptor agonist)
SAPPHIRE Aurora-GT™ eNOS Gene Therapy
Genetically-Enhanced Mesenchymal stem cells (GEM)